Trials / Sponsors / Southern China Urology Cancer Consortium
Southern China Urology Cancer Consortium
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients Self Efficacy, Adverse Drug Event, Carcinoma, Renal Cell | Phase 2 | 2014-07-01 |